Home -
Products -
Chromatin/Epigenetic -
Epigenetic Reader Domain -
3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
CAS No. 24365-65-9
3-methyl-1,2,3,4-tetrahydroquinazolin-2-one( —— )
Catalog No. M28377 CAS No. 24365-65-9
3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 2MG | 31 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 663 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
-
NoteResearch use only, not for human use.
-
Brief Description3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
-
Description3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24365-65-9
-
Formula Weight162.192
-
Molecular FormulaC9H10N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1Cc2ccccc2NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jian Tang, et al. Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum. Phytother Res. 2010 Jun;24(6):821-6.
molnova catalog
related products
-
PBRM1-BD2-IN-5
PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, with dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5 respectively, and an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2.
-
ZEN-3694
ZEN-3694 (ZEN 3694) is a bromo-structural domain extra-terminal inhibitor (BETi) with activity in androgen signaling inhibitor (ASI) resistance models and can be used in combination with enzalutamide to study metastatic desmoplasia-resistant prostate cancer.
-
OXF BD 02
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
Cart
sales@molnova.com